VIEWS: 2 PAGES: 1 CATEGORY: Medicine POSTED ON: 5/30/2010
Shields et al. from Wayne State University (Detroit, MI) reported in the July 15 issue of Clinical Cancer Research (2008;14:4463-4468) on methods to assess the reproducibility of measurement of fluorothymidine (FLT) retention in patients with nonsmall cell lung cancer (NSCLC), as part of a larger effort to apply ^sup 18^F-FLT PET in monitoring antineoplastic therapy.
Pages to are hidden for
"PET and Proliferation Monitoring"Please download to view full document